CDKN2A and cancer: In contrast, 80% of the RT2.CRISPR-Cdkn2a-cancer cells grew in syngeneic mice (Supplementary Fig. 5c), demonstrating that natural immune responses required the senescence-inducing Cdkn2a gene to control these highly immunogenic cancer cells (Fig. 1a, upper panel).